TY - JOUR
T1 - Impact of β-hydroxy β-methylbutyrate (HMB) on age-related functional deficits in mice
AU - Munroe, Michael
AU - Pincu, Yair
AU - Merritt, Jennifer
AU - Cobert, Adam
AU - Brander, Ryan
AU - Jensen, Tor
AU - Rhodes, Justin
AU - Boppart, Marni D.
N1 - Publisher Copyright:
© 2016 Elsevier Inc.
PY - 2017/1/1
Y1 - 2017/1/1
N2 - β-Hydroxy β-methylbutyrate (HMB) is a metabolite of the essential amino acid leucine. Recent studies demonstrate a decline in plasma HMB concentrations in humans across the lifespan, and HMB supplementation may be able to preserve muscle mass and strength in older adults. However, the impact of HMB supplementation on hippocampal neurogenesis and cognition remains largely unexplored. The purpose of this study was to simultaneously evaluate the impact of HMB on muscle strength, neurogenesis and cognition in young and aged mice. In addition, we evaluated the influence of HMB on muscle-resident mesenchymal stem/stromal cell (Sca-1+ CD45−; mMSC) function to address these cells potential to regulate physiological outcomes. Three month-old (n = 20) and 24 month-old (n = 18) female C57BL/6 mice were provided with either Ca-HMB or Ca-Lactate in a sucrose solution twice per day for 5.5 weeks at a dose of 450 mg/kg body weight. Significant decreases in relative peak and mean force, balance, and neurogenesis were observed in aged mice compared to young (age main effects, p ≤ 0.05). Short-term HMB supplementation did not alter activity, balance, neurogenesis, or cognitive function in young or aged mice, yet HMB preserved relative peak force in aged mice. mMSC gene expression was significantly reduced with age, but HMB supplementation was able to recover expression of select growth factors known to stimulate muscle repair (HGF, LIF). Overall, our findings demonstrate that while short-term HMB supplementation does not appear to affect neurogenesis or cognitive function in young or aged mice, HMB may maintain muscle strength in aged mice in a manner dependent on mMSC function.
AB - β-Hydroxy β-methylbutyrate (HMB) is a metabolite of the essential amino acid leucine. Recent studies demonstrate a decline in plasma HMB concentrations in humans across the lifespan, and HMB supplementation may be able to preserve muscle mass and strength in older adults. However, the impact of HMB supplementation on hippocampal neurogenesis and cognition remains largely unexplored. The purpose of this study was to simultaneously evaluate the impact of HMB on muscle strength, neurogenesis and cognition in young and aged mice. In addition, we evaluated the influence of HMB on muscle-resident mesenchymal stem/stromal cell (Sca-1+ CD45−; mMSC) function to address these cells potential to regulate physiological outcomes. Three month-old (n = 20) and 24 month-old (n = 18) female C57BL/6 mice were provided with either Ca-HMB or Ca-Lactate in a sucrose solution twice per day for 5.5 weeks at a dose of 450 mg/kg body weight. Significant decreases in relative peak and mean force, balance, and neurogenesis were observed in aged mice compared to young (age main effects, p ≤ 0.05). Short-term HMB supplementation did not alter activity, balance, neurogenesis, or cognitive function in young or aged mice, yet HMB preserved relative peak force in aged mice. mMSC gene expression was significantly reduced with age, but HMB supplementation was able to recover expression of select growth factors known to stimulate muscle repair (HGF, LIF). Overall, our findings demonstrate that while short-term HMB supplementation does not appear to affect neurogenesis or cognitive function in young or aged mice, HMB may maintain muscle strength in aged mice in a manner dependent on mMSC function.
KW - Aging
KW - Cognition
KW - Mesenchymal stem cells
KW - Neurogenesis
KW - Nutrition
UR - http://www.scopus.com/inward/record.url?scp=85001099590&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85001099590&partnerID=8YFLogxK
U2 - 10.1016/j.exger.2016.11.010
DO - 10.1016/j.exger.2016.11.010
M3 - Article
C2 - 27887984
AN - SCOPUS:85001099590
SN - 0531-5565
VL - 87
SP - 57
EP - 66
JO - Experimental Gerontology
JF - Experimental Gerontology
ER -